The 10-year Treasury now pays 5.31%, and most dividend stocks simply cannot clear that bar.
Omega Healthcare Investors is downgraded from buy to hold as growth appears fully priced in near current levels. OHI delivered strong Q2 results, with AFFO guidance raised to $3.22–$3.26 and a 4.2% growth rate amid challenging conditions. Balance sheet strength is notable, with net debt to EBITDA at 3.3x and an 87% FAD payout ratio supporting a secure 5.71% dividend yield.
Omega Healthcare remains Buy rated, offering a near 6% yield and structural advantages in skilled nursing real estate. OHI's upcoming earnings are expected to be quietly strong, with AFFO/share modeled at $0.81 versus the Street's $0.80. Recent acquisitions and stable rental income support 4% y/y revenue growth, while interest expense and G&A remain contained.
| Health Care REITs Industry | Real Estate Sector | Matthew Gourmand CEO | XDUS Exchange | US6819361006 ISIN |
| US Country | 69 Employees | 3 Aug 2026 Last Dividend | - Last Split | 7 Aug 1992 IPO Date |
Omega is a specialized Real Estate Investment Trust (REIT) focusing on the long-term healthcare industry. It takes a strategic investment approach in skilled nursing and assisted living facilities, addressing the growing need for healthcare infrastructure and services. With a comprehensive portfolio managed under a triple-net lease structure, Omega partners with a wide array of healthcare providers. This arrangement ensures stable and predictable cash flows, guided by the company's expertise in real estate and healthcare sector dynamics. Operating across the U.S. and expanding into the U.K., Omega's geographic diversity offers a broad exposure to different healthcare markets and regulatory environments, further solidifying its position within the specialized REIT sector.